Glycemic control of type 2 diabetic patients with coronavirus disease during hospitalization: A proposal for early insulin therapy

Afif Nakhleh; Naim Shehadeh

doi:10.1152/ajpendo.00163.2020

Glycemic control of type 2 diabetic patients with coronavirus disease during hospitalization: A proposal for early insulin therapy

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	E835-E837
Journal	American Journal of Physiology - Endocrinology and Metabolism
Volume	318
Issue number	6
DOIs	https://doi.org/10.1152/ajpendo.00163.2020
State	Published - 13 May 2020
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Angiotensin-Converting Enzyme 2
Animals
Blood Glucose/drug effects
COVID-19
Coronavirus Infections/blood
Diabetes Mellitus, Type 2/blood
Drug Administration Schedule
Early Medical Intervention/methods
Glycated Hemoglobin A/drug effects
Hospitalization
Humans
Hypoglycemic Agents/administration & dosage
Insulin/administration & dosage
Mice
Mice, Knockout
Pandemics
Peptidyl-Dipeptidase A/physiology
Pneumonia, Viral/blood
Recombinant Proteins/therapeutic use
Time Factors

All Science Journal Classification (ASJC) codes

Physiology (medical)
Physiology
Endocrinology, Diabetes and Metabolism

Access to Document

10.1152/ajpendo.00163.2020

Cite this

@article{394972de656940d7b302e30cc6f7aa00,

title = "Glycemic control of type 2 diabetic patients with coronavirus disease during hospitalization: A proposal for early insulin therapy",

keywords = "Angiotensin-Converting Enzyme 2, Animals, Blood Glucose/drug effects, COVID-19, Coronavirus Infections/blood, Diabetes Mellitus, Type 2/blood, Drug Administration Schedule, Early Medical Intervention/methods, Glycated Hemoglobin A/drug effects, Hospitalization, Humans, Hypoglycemic Agents/administration & dosage, Insulin/administration & dosage, Mice, Mice, Knockout, Pandemics, Peptidyl-Dipeptidase A/physiology, Pneumonia, Viral/blood, Recombinant Proteins/therapeutic use, Time Factors",

author = "Afif Nakhleh and Naim Shehadeh",

year = "2020",

month = may,

day = "13",

doi = "10.1152/ajpendo.00163.2020",

language = "الإنجليزيّة",

volume = "318",

pages = "E835--E837",

journal = "American Journal of Physiology - Endocrinology and Metabolism",

issn = "0193-1849",

publisher = "American Physiological Society",

number = "6",

}

TY - JOUR

T1 - Glycemic control of type 2 diabetic patients with coronavirus disease during hospitalization

T2 - A proposal for early insulin therapy

AU - Nakhleh, Afif

AU - Shehadeh, Naim

PY - 2020/5/13

Y1 - 2020/5/13

KW - Angiotensin-Converting Enzyme 2

KW - Animals

KW - Blood Glucose/drug effects

KW - COVID-19

KW - Coronavirus Infections/blood

KW - Diabetes Mellitus, Type 2/blood

KW - Drug Administration Schedule

KW - Early Medical Intervention/methods

KW - Glycated Hemoglobin A/drug effects

KW - Hospitalization

KW - Humans

KW - Hypoglycemic Agents/administration & dosage

KW - Insulin/administration & dosage

KW - Mice

KW - Mice, Knockout

KW - Pandemics

KW - Peptidyl-Dipeptidase A/physiology

KW - Pneumonia, Viral/blood

KW - Recombinant Proteins/therapeutic use

KW - Time Factors

UR - http://www.scopus.com/inward/record.url?scp=85084693802&partnerID=8YFLogxK

U2 - 10.1152/ajpendo.00163.2020

DO - 10.1152/ajpendo.00163.2020

M3 - رسالة

C2 - 32401039

SN - 0193-1849

VL - 318

SP - E835-E837

JO - American Journal of Physiology - Endocrinology and Metabolism

JF - American Journal of Physiology - Endocrinology and Metabolism

IS - 6

ER -

Glycemic control of type 2 diabetic patients with coronavirus disease during hospitalization: A proposal for early insulin therapy

UN SDGs

Keywords

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this